189 related articles for article (PubMed ID: 37691586)
1. Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey.
Qin S; Li Y; Wang L; Zhao X; Ma X; Gao GF
Emerg Microbes Infect; 2023 Dec; 12(2):2258232. PubMed ID: 37691586
[TBL] [Abstract][Full Text] [Related]
2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
4. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
Huhn G; Poorbaugh J; Zhang L; Beasley S; Nirula A; Brothers J; Welbel S; Wilson J; Gillani S; Weber KM; Morack R; Keckler K; Benschop RJ
PLoS One; 2022; 17(9):e0273323. PubMed ID: 36083883
[TBL] [Abstract][Full Text] [Related]
6. Symptom monitoring after coronavirus disease 2019 (COVID-19) vaccination in a large integrated healthcare system: Separating symptoms from severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection.
Shenoy ES; Wickner PG; West LR; Banerji A; Blumenthal KG; Centi AJ; Gottlieb A; Hashimoto DM; Kim E; Kim M; Lee H; Simpson LA; Landman AB
Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1439-1446. PubMed ID: 34726142
[TBL] [Abstract][Full Text] [Related]
7. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review.
Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H
Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125
[No Abstract] [Full Text] [Related]
8. The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
Bird O; Galiza EP; Baxter DN; Boffito M; Browne D; Burns F; Chadwick DR; Clark R; Cosgrove CA; Galloway J; Goodman AL; Heer A; Higham A; Iyengar S; Jeanes C; Kalra PA; Kyriakidou C; Bradley JM; Munthali C; Minassian AM; McGill F; Moore P; Munsoor I; Nicholls H; Osanlou O; Packham J; Pretswell CH; San Francisco Ramos A; Saralaya D; Sheridan RP; Smith R; Soiza RL; Swift PA; Thomson EC; Turner J; Viljoen ME; Heath PT; Chis Ster I
Epidemiol Infect; 2024 Jan; 152():e37. PubMed ID: 38250791
[TBL] [Abstract][Full Text] [Related]
9. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of children and their family members with family clusters of SARS-CoV-2 Omicron variant infection in Shanghai, China: an analysis of 380 cases].
Bian XL; Guo Z; Zhang K; Li MC; Wu ZM; Jiang Q; Guo MM; Fan SN; Chen JJ; Hui L; Zheng F; Zhang JP
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1085-1091. PubMed ID: 36305107
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study.
da Costa E Silva GR; Moura WÉA; Dos Santos KC; Gomes DO; Bandeira GN; Guimarães RA; Rosso CFW; Bazilio GS; Leite VRMC; Caetano KAA; Carneiro MADS; Teles SA
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674238
[TBL] [Abstract][Full Text] [Related]
12. Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China.
Xu T; Chen Y; Zhan W; Chung KF; Qiu Z; Huang K; Chen R; Xie J; Wang G; Zhang M; Wang X; Yao H; Liao X; Zhang Y; Zhang G; Zhang W; Sun D; Zhu J; Jiang S; Feng J; Zhao J; Sun G; Huang H; Zhang J; Wang L; Wu F; Li S; Xu P; Chi C; Chen P; Jiang M; He W; Huang L; Luo W; Li S; Zhong N; Lai K;
JMIR Public Health Surveill; 2024 Feb; 10():e47453. PubMed ID: 38315527
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and long-term symptoms associated with SARS-CoV-2 omicron infection in children aged 0-17 years in Beijing: a single-center study.
Li J; Li J; Cao L; Wang L; Chen X; Niu W; Dang L; Dai S; Wang Y; Ge M; Liu W; Song Q; Xu W; Ma L
Front Pediatr; 2024; 12():1332020. PubMed ID: 38813546
[TBL] [Abstract][Full Text] [Related]
14. Symptom profiles and vaccination status for COVID-19 after the adjustment of the dynamic zero-COVID policy in China: An observational study.
Zhang H; Lu Z; Yang F; Chen H; Zhang L; Zhao H; Chen Y
J Med Virol; 2023 Jul; 95(7):e28893. PubMed ID: 37394796
[TBL] [Abstract][Full Text] [Related]
15. Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination.
Hara M; Furue T; Fukuoka M; Iwanaga K; Matsuishi E; Miike T; Sakamoto Y; Mukai N; Kinugasa Y; Shigyo M; Sonoda N; Tanaka M; Arase Y; Tanaka Y; Nakashima H; Irie S; Hirota Y
Hum Vaccin Immunother; 2023 Aug; 19(2):2226575. PubMed ID: 37357433
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
[TBL] [Abstract][Full Text] [Related]
17. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
18. Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections.
Woo MS; Mayer C; Brehm TT; Andersen G; Weigel A; Löwe B; Lohse AW; Addo MM; Gerloff C; Knobloch JKM; Schulze Zur Wiesch J; Friese MA
Brain Commun; 2023; 5(2):fcad092. PubMed ID: 37038497
[TBL] [Abstract][Full Text] [Related]
19. New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.
Vaira LA; De Vito A; Lechien JR; Chiesa-Estomba CM; Mayo-Yàñez M; Calvo-Henrìquez C; Saussez S; Madeddu G; Babudieri S; Boscolo-Rizzo P; Hopkins C; De Riu G
Laryngoscope; 2022 Feb; 132(2):419-421. PubMed ID: 34812498
[TBL] [Abstract][Full Text] [Related]
20. Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020.
Vahey GM; Marshall KE; McDonald E; Martin SW; Tate JE; Midgley CM; Killerby ME; Kawasaki B; Herlihy RK; Alden NB; Staples JE;
Emerg Infect Dis; 2021 Feb; 27(2):385-395. PubMed ID: 33496225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
